Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  mesna
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 314 for your search:
Start Over
Phase II/III Pilot Combination Chemotherapy with ARA-C/VP-16/IPP plus Mesna plus Intrathecal MTX in Pediatric Patients with Recurrent Nonlymphoblastic Lymphoma (Summary Last Modified 07/90)
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: NCI-85-C-62, NCI-T85-0096N, T85-0096
Phase III Randomized Study of CDDP/IFF vs BIP (BLEO/IFF/CDDP) in Patients with Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix
Phase: Phase III
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: GOG-149, GOG-0149
Phase III Randomized Study of Adjuvant Chemotherapy with High-Dose Doxorubicn/Cyclophosphamide vs Doxorubicin Followed by Cyclophosphamide in Women with High-Risk Breast Cancer and 0-3 Positive Nodes
Phase: Phase III
Type: Treatment
Status: Closed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9313, CLB-9394, E-S9313, NCCTG-933051, INT-0137
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: CDR0000063311, EORTC-06931, NCT00002549
Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI, Other
Protocol IDs: CDR0000063574, MDA-DM-94017, NCI-T94-0040D, DM94-017, T94-0040, NCT00002565
Phase III Randomized Study of Standard-Dose MAID (Mesna/DOX/IFF/DTIC) vs Dose-Intensified MAID with G-CSF for Advanced Adult Soft Tissue Sarcoma (Summary Last Modified 12/97)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: FRE-FNCLCC-PALSAR-93, NCI-F94-0018
Phase III Randomized Study of High-Dose vs Low-Dose Docetaxel vs Standard Chemotherapy with Vinorelbine or Ifosfamide for Non-Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy (Summary Last Modified 08/97)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-95088, RP-56976-TAX-320, NCI-V96-0830
Phase III Randomized Study of Unrelated Donor BMT vs Continuing Chemotherapy for Childhood Acute Lymphoblastic Leukemia in First Relapse
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 15 at initial diagnosis
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-R2, EU-95039
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer
Phase: Phase III
Type: Health services research, Treatment
Status: Completed
Age: 16 to 65
Sponsor: Other
Protocol IDs: CDR0000064834, IBCSG-15-95, EU-96021, NCT00002784
Start Over